David Foulad
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Genetics top 10%
- Genetics top 10%
- Co-authors
- Mohammad AtefiMichael CernigliaAntoni RibasDeborah J. WongThomas G. GraeberBegonya Comin-AnduixAmanda LassenEarl Avramis
- Topics
- Immunotherapy and Immune Responses (6 papers)Virus-based gene therapy research (5 papers)CAR-T cell therapy research (5 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
David Foulad
17 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Oncology 481
- Molecular Biology 414
- Immunology 371
- Genetics 213
- Genetics 113
Countries citing papers authored by David Foulad
This map shows the geographic impact of David Foulad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Foulad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Foulad more than expected).
Fields of papers citing papers by David Foulad
This network shows the impact of papers produced by David Foulad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Foulad. The network helps show where David Foulad may publish in the future.
Co-authorship network of co-authors of David Foulad
This figure shows the co-authorship network connecting the top 25 collaborators of David Foulad. A scholar is included among the top collaborators of David Foulad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Foulad. David Foulad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 50 | |
| 3 | 1 | |
| 4 | 25 | |
| 5 | 51 | |
| 6 | 63 | |
| 7 | 285 | |
| 8 | 85 | |
| 9 | 38 | |
| 10 | 62 | |
| 11 | 12 | |
| 12 | 86 | |
| 13 | 1 | |
| 14 | 32 | |
| 15 | 76 | |
| 16 | 80 | |
| 17 | 53 |
About David Foulad
David Foulad is a scholar working on Immunology, Oncology and Genetics, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (481 citations), Immunology (371 citations) and Genetics (113 citations). David Foulad has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Mohammad Atefi, Michael Cerniglia, Antoni Ribas, Deborah J. Wong, Thomas G. Graeber, Begonya Comin-Anduix, Amanda Lassen, Earl Avramis, Lídia Robert and Bjoern Titz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.